Anyhow, it is RNA N6-methyladenosine modification, but not the mRNA or protein MYCN expression level alone is important in miR-98/MYCN axis-mediated inhibition of neuroblastoma progression. The gene discussed is MYCN; the disease is neuroblastoma.